United States - English - NLM (National Library of Medicine)

rebel distributors corp - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 375 mg - carefully consider the potential benefits and risks of naprelan® tablets and other treatment options before deciding to use naprelan® tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naprelan® tablets are indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis and acute gout. it is also indicated in the relief of mild to moderate pain and the treatment of primary dysmenorrhea. naprelan® is contraindicated in patients with known hypersensitivity to naproxen. naprelan® should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings- anaphylactoid reactions , and precautions- preexisting asthma ). naprelan® is contraindicated for the treatment of peri-operative pain in the setting of cor

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 375 mg - carefully consider the potential benefits and risks of naprelan® tablets and other treatment options before deciding to use naprelan® tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naprelan® tablets are indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis and acute gout. it is also indicated in the relief of mild to moderate pain and the treatment of primary dysmenorrhea. naprelan® is contraindicated in patients with known hypersensitivity to naproxen. naprelan® should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings- anaphylactoid reactions , and precautions- preexisting asthma ). naprelan® is contraindicated for the treatment of peri-operative pain in the setting of cor

United States - English - NLM (National Library of Medicine)

stat rx usa - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 750 mg - carefully consider the potential benefits and risks of naprelan® tablets and other treatment options before deciding to use naprelan® tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naprelan® tablets are indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis and acute gout. it is also indicated in the relief of mild to moderate pain and the treatment of primary dysmenorrhea. naprelan® is contraindicated in patients with known hypersensitivity to naproxen. naprelan® should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings- anaphylactoid reactions , and precautions- preexisting asthma ). naprelan® is contraindicated for the treatment of peri-operative pain in the setting of cor

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - spinosad manufacturing concentrate; cyromazine - topical solution/suspension - spinosad manufacturing concentrate ungrouped active 12.5 g/l; cyromazine triazine active 500.0 g/l - parasiticides - sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - blowfly | lice - bovicola spp.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - spinosad manufacturing concentrate - topical solution/suspension - spinosad manufacturing concentrate ungrouped active 20.0 g/l - parasiticides - sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - sheep body louse | damalinia ovis (prev. genus) | lice - synthetic pyrethroid re | sheep body lice

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - spinosad manufacturing concentrate; chlorhexidine digluconate - topical solution/suspension - spinosad manufacturing concentrate ungrouped active 2.8 g/kg; chlorhexidine digluconate guanidine active 0.39 g/kg - parasiticides - sheep - mulesing wound | sheep - wound | sheep marking wound - antibiotic - anti-infective | australian sheep blowfly | abrasions | abscesses | airsacculitis | antiseptic | avian mycoplasmas | blackhead | blowfly organophosphate resist | body odours | bowed tendons | broad spectrum | burns | coccidiosis | coliform complex | conjunctivitis | cowpox | cracks | crusts | dandruff | dermatological disorders | dermatosis | dry skin | dysentery | eczema | endometritis | enteric diseases | enzootic pneumonia | feed efficiency | fungal infections | girth galls | infections | inflammed pads | itching | keratolytic | lacerations | mastitis | mycoplasmas | odours | open wounds | otitis | pruritis | queensland itch | respiratory disease | saddle rash | salmonellosis | scabs | scaly skin | sheath rot | skin irritations | sores | swine dysentery | teat cracking | teat infections | topical infections | udder sores | weight gain | wire cuts | wounds

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - ractopamine hydrochloride - oral powder, pre-mix - ractopamine hydrochloride ungrouped active 20.0 g/kg - nutrition & metabolism - pig grower | grower finisher pig | pig grower/finisher - improve feed efficiency | increased carcass leanness | increased dressing percentage | productivity improvements | improving feed efficiency | increasing rate of weight gain

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - trenbolone acetate; oestradiol - parenteral implant, device - trenbolone acetate steroid-anabolic active 140.0 mg/im; oestradiol steroid-estrogen active 28.0 mg/im - nutrition & metabolism - steer (castrated male cattle) | beef | bovine | bullock (young) | male cattle - castrated - improve feed efficiency | promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - oestradiol benzoate; progesterone - parenteral implant, device - oestradiol benzoate steroid-estrogen active 20.0 mg/im; progesterone steroid-progestin active 200.0 mg/im - nutrition & metabolism - steer (castrated male cattle) | beef | bovine | bullock (young) | male cattle - castrated - promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - tylosin tartrate; trenbolone acetate; oestradiol - parenteral implant, device - tylosin tartrate antibiotic active 29.0 mg/im; trenbolone acetate steroid-anabolic active 200.0 mg/im; oestradiol steroid-estrogen active 20.0 mg/im - nutrition & metabolism - heifer - promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain